Shadow AI Is the New Shadow IT 
Addressing Cross-Border Transit Demand at the New Huanggang Port: Weixin Pay, Wonder and Koon Wing Motors Join Forces to Introduce ‘Wonder Transit X’ Smart Mobility Platform, Driving Digital Transformation of Green Minibuses and Fostering Public Transit Integration Between HK and the Chinese Mainland 
Hengrui Pharma Reports 2026 Interim Results as Innovation and Globalization Continue to Drive Business Momentum 
Onchain Foundation Becomes Strategic Shareholder of Trust Square Ecosystem AG to Accelerate Global Innovation Platform 
Champion REIT Announces 2026 Interim Results Core One Labs Announces Its Entrance into the Ketamine Space with Proposed Acquisition of Ketamine Infusion Centers of Texas
VANCOUVER, BC / ACCESSWIRE / February 4, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62)…
Evotec and Medical Center Hamburg-Eppendorf Enter Partnership to Develop iPSC-Based Tissue Therapy for Heart Failure
PARTNERSHIP AIMS TO DEVELOP A FIRST-IN-CLASS IPSC-DERIVED HEART TISSUE THERAPY PRODUCT TO TREAT HEART FAILURE…
Nexera Enters Confirmation Phase of Recent Discovery
SAN ANTONIO, TX and CALGARY, AB / ACCESSWIRE / February 4, 2021 / Nexera Energy…
LeanLife Adds to its Management Strength in Preperation for Launching Online Sales of Mike Tyson Branded Iron Energy Drink
VANCOUVER, BC / ACCESSWIRE / February 4, 2021 / LeanLife Health Inc. (CSE:LLP)(FSE:LL1)(OTC PINK:LHLNF) (the…
Molecular Partners and Novartis COVID-19 Antiviral Candidate, Ensovibep, Maintains Binding and Neutralization of New Viral Variants in vitro
New study shows that Molecular Partners’ tri-specific antiviral DARPin® candidates, ensovibep (MP0420) and the Company’s…
Brand-UR-Name Is In Business For You And Your Needs
JERSEY CITY, NJ / ACCESSWIRE / February 3, 2021 / Brand-UR-Name is a customizable clothing…
ibml launches new ibml FUSiON 7200 scanner to help customers accelerate their digitization initiatives
Remote working has accelerated a need for digitization. ibml FUSiON™ 7200 brings best in class…
Sequana Medical Announces Granting of Key alfapump DSR® Patents in U.S. and Europe
GHENT, Belgium, Feb. 04, 2021 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA), an…
Statement re Update on Hypertension Pilot Programme
DXS INTERNATIONAL PLC (AQSE: DXSP) Update on Hypertension Pilot Programme DXS International plc (“DXS”, the…
European Urology Focus has accepted a scientific article describing LIDDS Phase IIb study results with Liproca® Depot
UPPSALA, SWEDEN – LIDDS AB (publ) announces that a scientific article will be published in…
Roche reports solid results in 2020
Basel, 4 February 2021 Group sales increase 1%1 at constant exchange rates (CER); 5% decline…
argenx announces full exercise of underwriters’ option to purchase additional ADSs
Regulated information — Inside information February 4, 2021 Breda, the Netherlands — argenx SE (Euronext &…
Dr Daniel C. Chung appointed as Chief Medical Officer of SparingVision
Dr Daniel C. Chung appointed as Chief Medical Officer of SparingVision Former Spark Therapeutics head…
Dr Daniel C. Chung appointed as Chief Medical Officer of SparingVision
Dr Daniel C. Chung appointed as Chief Medical Officer of SparingVision Former Spark Therapeutics head…
Iterum Therapeutics plc Increases Previously Announced Bought Deal Public Offering of Ordinary Shares to $40.0 Million
DUBLIN, Ireland and CHICAGO, Feb. 03, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM)…
Idorsia announces financial results for 2020 – a successful year marked by outstanding clinical data
Allschwil, Switzerland – February 4, 2021 Idorsia Ltd (SIX: IDIA) today announced its financial results…
Issue of Equity on Exercise of Options/Vesting of Performance Share Awards
Acacia Pharma Group plc Issue of Equity on Exercise of Options/Vesting of Performance Share Awards…
Novavax and Government of Switzerland Announce Agreement in Principle to Supply COVID-19 Vaccine
Switzerland to purchase six million doses of the Novavax vaccine candidate, NVX-CoV2373 GAITHERSBURG, Md., Feb….
Sana Announces Upsized Pricing of Initial Public Offering
SEATTLE, Feb. 03, 2021 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (Sana) (Nasdaq: SANA), a company…
Revolution Medicines Announces Pricing of Upsized $260.9 Million Public Offering of Common Stock
REDWOOD CITY, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD) today…